Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07189585 · ClinicalTrials.gov registry record · Phase 2
Inulin Supplementation for Reducing Inflammation and Knee Pain in Older Adults With Osteoarthritis
A Phase 2 study, sponsored by Yale University.
- Not yet
- Registry status
- Phase 2
- Development phase
- 84
- Enrollment target
NCT07189585 is a Phase 2 study that has not yet begun recruiting, run by Yale University. The registered enrollment target is 84 participants.
The verdict
NCT07189585, a Phase 2 study, has not yet begun recruiting, sponsored by Yale University.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 84 participants
- Enrollment target
Study Summary
This study will test whether inulin, a type of dietary fiber, can reduce inflammation in older adults with knee osteoarthritis. Inflammation in the body may contribute to both joint pain and the progression of osteoarthritis. Inulin is a prebiotic fiber that may improve gut health and reduce lipopolysaccharide (LPS), a marker of bacterial products in the blood that is linked to inflammation. In this trial, participants with knee osteoarthritis will be randomly assigned to receive either inulin or a placebo (maltodextrin) for 8 weeks. The study will measure changes in blood LPS levels, knee pain, and other markers of inflammation. The goal is to determine whether inulin supplementation can improve pain and reduce inflammation in people with knee osteoarthritis.
Interventions
- DRUG Maltodextrin (Placebo)
- DRUG inulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2026-11-01 |
| Est. Completion | 2027-07-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07189585
The ClinicalTrials.gov registry entry for NCT07189585 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Maltodextrin (Placebo) is the first listed.
NCT07189585 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07189585 about?
NCT07189585 is a clinical study titled "Inulin Supplementation for Reducing Inflammation and Knee Pain in Older Adults With Osteoarthritis". This study will test whether inulin, a type of dietary fiber, can reduce inflammation in older adults with knee osteoarthritis. Inflammation in the body may contribute to both joint pain and the progression of osteoarthritis. Inulin is a prebiotic fiber that may improve gut health and reduce lipopol...
What is the current status of trial NCT07189585?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 84 participants. The study started on 2026-11-01. Estimated completion is 2027-07-31.
What interventions are being tested in trial NCT07189585?
The interventions under investigation include: Maltodextrin (Placebo) (DRUG), inulin (DRUG).
Who is sponsoring clinical trial NCT07189585?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.